Current and future treatment of HIV infection.
After much frustration in the last decade, HIV therapeutics is an emerging discipline. Over the past few years a number of new agents have been evaluated, including such antiviral drugs as zidovudine, dideoxycytidine and dideoxyinosine, and immunomodulators such as alpha interferon and interleukin-2. The author discusses these and other agents and the prospects for combination therapy.
Bartlett
J A
JA
Department of Medicine, Duke University Medical Center.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D005544:Forecasting; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D015215:Zidovudine / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D000998:Antiviral Agents; D015215:Zidovudine